UPH Stock Chart & Stats
€66.00
€0.50(0.59%)
At close: 4:00 PM EST
€66.00
€0.50(0.59%)
Day’s Range― - ―
52-Week Range€49.60 - €80.50
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€978.99M
Enterprise Value€1.29B
Total Cash (Recent Filing)€28.44M
Total Debt (Recent Filing)€362.83M
Price to Earnings (P/E)144.3
Beta0.38
Next Earnings
Jul 30, 2026EPS Estimate
0.71Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.50
Shares Outstanding15,218,789
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-2.41
Price to Book (P/B)2.49
Price to Sales (P/S)1.52
P/FCF Ratio19.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€81.09Price Target Upside22.87% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)2.55
Revenue Forecast (FY)€737.24M
Bulls Say, Bears Say
Bulls Say
Revenue Growth & Visit TrendsSustained top-line growth and rising visits per clinic indicate improved utilization and referral traction. Higher same-store revenue and visit recovery provide a durable operating lever: incremental visits scale fixed clinic costs and support predictable revenue growth over the next 2–6 months.
Cash Generation & FCFSolid operating and free cash flow provide recurring internal funding for acquisitions, partner investments, dividends and working capital. Reliable cash generation supports capital allocation flexibility and cushions the business through seasonality or reimbursement timing differences.
Industrial Injury Prevention (IIP) MomentumFaster growth and higher margins in the IIP segment diversify revenue and boost overall profitability potential. Employer-contracted services are stickier and higher margin, offering structural upside as the company scales onsite programs and converts acquisitions into repeatable, cash-generative contracts.
Bears Say
Compressed Profitability & Low ROEDespite revenue growth, sharply reduced margins and ROE signal weaker earnings quality and impaired return on capital. Low profitability limits reinvestment and dividend coverage, making long-term performance sensitive to cost control, reimbursement mix, and successful margin-restoring initiatives.
Rising Operating Costs Pressuring PT MarginsHigher payroll, contract labor and per-visit operating costs are squeezing core PT margins. If cost trends persist, margin recovery from visit growth will be muted, requiring sustained productivity gains or pricing power to restore historical profitability levels over the medium term.
Higher Leverage And Reduced CashAcquisitions and noncontrolling-interest purchases increased borrowings while cash declined, raising interest and liquidity sensitivity. Even with a larger credit facility, elevated leverage reduces flexibility and increases exposure to higher rates or slower cash conversion in a downside scenario.
US Physical Therapy News
UPH FAQ
What was U.s. Physical Therapy’s price range in the past 12 months?
U.s. Physical Therapy lowest stock price was €49.60 and its highest was €80.50 in the past 12 months.
What is U.s. Physical Therapy’s market cap?
U.s. Physical Therapy’s market cap is €978.99M.
When is U.s. Physical Therapy’s upcoming earnings report date?
U.s. Physical Therapy’s upcoming earnings report date is Jul 30, 2026 which is in 19 days.
How were U.s. Physical Therapy’s earnings last quarter?
U.s. Physical Therapy released its earnings results on May 06, 2026. The company reported €0.403 earnings per share for the quarter, missing the consensus estimate of €0.453 by -€0.05.
Is U.s. Physical Therapy overvalued?
According to Wall Street analysts U.s. Physical Therapy’s price is currently Undervalued.
Does U.s. Physical Therapy pay dividends?
U.s. Physical Therapy does not currently pay dividends.
What is U.s. Physical Therapy’s EPS estimate?
U.s. Physical Therapy’s EPS estimate is 0.71.
How many shares outstanding does U.s. Physical Therapy have?
U.s. Physical Therapy has 15,218,789 shares outstanding.
What happened to U.s. Physical Therapy’s price movement after its last earnings report?
U.s. Physical Therapy reported an EPS of €0.403 in its last earnings report, missing expectations of €0.453. Following the earnings report the stock price went up 2.48%.
Which hedge fund is a major shareholder of U.s. Physical Therapy?
Currently, no hedge funds are holding shares in DE:UPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
US Physical Therapy Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€81.09 (22.87% Upside)
€81.09 (22.87% Upside)
Blogger Sentiment
Bearish
DE:UPH Sentiment 70%
Sector Average 69%
Sector Average 69%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.53%
12-Months-Change
Fundamentals
Return on Equity
0.24%
Trailing 12-Months
Asset Growth
5.29%
Trailing 12-Months
Company Description
U.s. Physical Therapy
U.S. Physical Therapy, Inc., through its various subsidiaries, manages a network of outpatient physical therapy facilities. These clinics deliver a range of services, including rehabilitation before and after surgery, treatment for musculoskeletal conditions, recovery from sports-related trauma, proactive health measures, assistance for workers recovering from injuries, and care for neurological conditions. The company's business is divided into two primary divisions: Physical Therapy Operations and Industrial Injury Prevention Services. Within its industrial segment, it provides specialized services like on-site injury avoidance and recovery programs, strategies for enhancing physical performance, pre-employment screening tests, assessments of an individual's work capacity, and workplace ergonomic reviews. These offerings are delivered by licensed physical therapists and expert certified athletic trainers to a diverse clientele, including Fortune 500 corporations, insurance providers, and their associated contractors. By the end of 2021, specifically December 31st, the company had established 591 operational clinics across 39 states, in addition to overseeing 35 other physical therapy sites. Established in 1990, the company maintains its headquarters in Houston, Texas.
UPH Company Deck
UPH Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated solid top-line growth, strengthening visit trends, and strategic progress (IIP margin expansion, hospital affiliations starting, expanded credit facility and targeted technology/ cash-program rollouts). Near-term pressures—weather-related lost visits, higher operating and corporate costs, elevated tax rate, and GAAP per-share impacts from revaluations—temporarily weighed on margins and net income. Management affirmed full-year adjusted EBITDA guidance, highlighted recoveries as seasonality normalizes and hospital ramps accelerate, and presented confidence in execution of strategic initiatives.View all DE:UPH earnings summariesUPH Stock 12 Month Forecast
Average Price Target
€81.09
▲(22.87% Upside)
Technical Analysis
AMN Healthcare Services
―
Healthcare Services
―
Pediatrix Medical Group
―
Select Medical
―
Pennant Group
―
Options Prices
Currently, No data available
---